Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice (Q39828923)

15 September 2017

Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice (English)

1 reference

15 September 2017

0 references

0 references

1 reference

1 reference

Hui Hu

1

1 reference

15 September 2017

Ling Tao

2

1 reference

15 September 2017

Yabin Wang

3

1 reference

15 September 2017

Liying Chen

4

1 reference

15 September 2017

Jihong Yang

5

1 reference

15 September 2017

Hanzhong Wang

6

1 reference

15 September 2017

5 July 2009

1 reference

15 September 2017

Biotechnology Letters

1 reference

15 September 2017

31

1 reference

15 September 2017

11

1 reference

15 September 2017

1685-1693

1 reference

https://scigraph.springernature.com/pub.10.1007/s10529-009-0061-y

15 September 2017

0 references

cites work

SARS--beginning to understand a new virus

1 reference

12 December 2020

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

1 reference

12 December 2020

Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids

1 reference

12 December 2020

Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies

1 reference

12 December 2020

DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus

1 reference

12 December 2020

Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression

1 reference

12 December 2020

Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers

1 reference

12 December 2020

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

1 reference

12 December 2020

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

12 December 2020

Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS.

1 reference

12 December 2020

Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.

1 reference

12 December 2020

Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins

1 reference

12 December 2020

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

1 reference

12 December 2020

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine

1 reference

12 December 2020

Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.

1 reference

12 December 2020

Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

1 reference

12 December 2020

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation

1 reference

12 December 2020

DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

1 reference

12 December 2020

In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice

1 reference

12 December 2020

Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal.

1 reference

12 December 2020

Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.

1 reference

12 December 2020

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates

1 reference

12 December 2020

Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice

1 reference

12 December 2020

Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants

1 reference

12 December 2020

10.1007/S10529-009-0061-Y

Identifiers

DOI

1 reference

15 September 2017

0 references

1 reference